Association between the c. 2495 A>G ATP7B Polymorphism and Sporadic Alzheimer's Disease
- PMID: 21760992
- PMCID: PMC3132548
- DOI: 10.4061/2011/973692
Association between the c. 2495 A>G ATP7B Polymorphism and Sporadic Alzheimer's Disease
Abstract
Nonceruloplasmin-bound copper ("free") is reported to be elevated in Alzheimer's disease (AD). In Wilson's disease (WD) Cu-ATPase 7B protein tightly controls free copper body levels. To explore whether the ATP7B gene harbours susceptibility loci for AD, we screened 180 AD chromosomes for sequence changes in exons 2, 5, 8, 10, 14, and 16, where most of the Mediterranean WD-causing mutations lie. No WD mutation, but sequence changes corresponding to c.1216 T>G Single-Nucleotide Polymorphism (SNP) and c.2495 A>G SNP were found. Thereafter, we genotyped 190 AD patients and 164 controls for these SNPs frequencies estimation. Logistic regression analyses revealed either a trend for the c.1216 SNP (P = .074) or a higher frequency for c.2495 SNP of the GG genotype in patients, increasing the probability of AD by 74% (P = .028). Presence of the GG genotype in ATP7B c.2495 could account for copper dysfunction in AD which has been shown to raise the probability of the disease.
Figures


Similar articles
-
Association of K832R and R952K SNPs of Wilson's disease gene with Alzheimer's disease.J Alzheimers Dis. 2012;29(4):913-9. doi: 10.3233/JAD-2012-111997. J Alzheimers Dis. 2012. PMID: 22356903
-
New mutations and polymorphisms of the ATP7B gene in sporadic Wilson disease.Eur J Med Genet. 2014 Sep;57(9):498-502. doi: 10.1016/j.ejmg.2014.04.016. Epub 2014 May 28. Eur J Med Genet. 2014. PMID: 24878384
-
Non-ceruloplasmin bound copper and ATP7B gene variants in Alzheimer's disease.Metallomics. 2016 Sep 1;8(9):863-73. doi: 10.1039/c6mt00101g. Epub 2016 Aug 8. Metallomics. 2016. PMID: 27499330 Review.
-
[Genotype and phenotype correlation in Chinese patients with Wilson's Disease].Zhonghua Er Ke Za Zhi. 2003 Jan;41(1):35-8. Zhonghua Er Ke Za Zhi. 2003. PMID: 14761325 Chinese.
-
ATP7B (WND) protein.Int J Biochem Cell Biol. 1998 Oct;30(10):1063-7. doi: 10.1016/s1357-2725(98)00073-9. Int J Biochem Cell Biol. 1998. PMID: 9785470 Review.
Cited by
-
Copper phenotype in Alzheimer's disease: dissecting the pathway.Am J Neurodegener Dis. 2013 Jun 21;2(2):46-56. Print 2013. Am J Neurodegener Dis. 2013. PMID: 23844331 Free PMC article.
-
Does Ceruloplasmin Defend Against Neurodegenerative Diseases?Curr Neuropharmacol. 2019;17(6):539-549. doi: 10.2174/1570159X16666180508113025. Curr Neuropharmacol. 2019. PMID: 29737252 Free PMC article. Review.
-
Role of the P-Type ATPases, ATP7A and ATP7B in brain copper homeostasis.Front Aging Neurosci. 2013 Aug 23;5:44. doi: 10.3389/fnagi.2013.00044. eCollection 2013. Front Aging Neurosci. 2013. PMID: 23986700 Free PMC article.
-
Exposure of metal toxicity in Alzheimer's disease: An extensive review.Front Pharmacol. 2022 Aug 29;13:903099. doi: 10.3389/fphar.2022.903099. eCollection 2022. Front Pharmacol. 2022. PMID: 36105221 Free PMC article. Review.
-
Zinc deficiency and zinc therapy efficacy with reduction of serum free copper in Alzheimer's disease.Int J Alzheimers Dis. 2013;2013:586365. doi: 10.1155/2013/586365. Epub 2013 Oct 10. Int J Alzheimers Dis. 2013. PMID: 24224111 Free PMC article. Review.
References
-
- Arnal N, Cristalli DO, de Alaniz MJT, Marra CA. Clinical utility of copper, ceruloplasmin, and metallothionein plasma determinations in human neurodegenerative patients and their first-degree relatives. Brain Research. 2010;1319:118–130. - PubMed
-
- Bocca B, Forte G, Petrucci F, et al. Monitoring of chemical elements and oxidative damage in patients affected by Alzheimer’s disease. Annali dell’Istituto Superiore di Sanita. 2005;41(2):197–203. - PubMed
LinkOut - more resources
Full Text Sources